Jinyao Pharmaceutical: Dexamethasone bulk drug approved for marketing
2026-11-19 15:51:34
According to CoinMeta, on November 19th, Jinyao Pharmaceutical announced that the company had received the 'Approval Notice for the Marketing Application of Dexamethasone as a Chemical Raw Drug' issued by the National Medical Products Administration. This drug is mainly used for allergic and autoimmune inflammatory diseases.
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.
Follow WalletJYS official accounts to stay updated

Hot Articles
Refresh

What Is Bitmine? Why the Largest ETH Treasury Halted Buys
11-17 11:29

NVIDIA's stock tumbles 9% after the latest announcement; what impact will NVIDIA's decline have on the AI industry?
11-12 16:08

Is the Tangem wallet secure? No need to memorize a mnemonic phrase, can beginners use it with confidence?
11-12 17:31

SOL Currency's Latest Price Outlook: Can It Break Through the $90 Barrier?
11-11 11:59

Dow Jones 1,000-Point Swings: CPI Reversal or Bull Trap?
11-10 16:56



